Global CRISPR-CAS9 Gene Editing Technologies Market Ovrview

Market Scenario

The global CRISPR-CAS9 gene editing technologies market is expected to grow at a healthy CAGR of 14.6% during 2019-2026.

Gene editing is the mode
biotechnological techniques designed to alter the genomes of living organisms for health or economic benefits. Now-a-days, gene editing isnot only used in the medical sector but also in agricultural sector. CRISPR/Cas9 is recently developed technology that is effectively and specifically changes genes within organisms. The global CRISPR/Cas9 gene editing market is majorly driven by increasing gove
ment funding for genomics projects, increasing application of genomics in medical field, and growing prevalence of infectious and genetic diseases. Additionally, rapid advancement in technology and increasing demand for genetically modified crops has fueled the growth of the market. 

However, gene editing and research is a brainstorming process and requires skilled professionals. Additionally, high cost of research and long approval time for the products may slow the growth of the market.

Segmentation

The global CRISPR-CAS9 gene editing technologies market is segmented on the basis ofapplications and end users.

On the basis of application, the CRISPR-CAS9 gene editing technologies market is segmented intogenome engineering, disease models, RNA editing, knockdown/activation, and others. Genetic engineering is further segmented into medicine, agriculture, research, and other. Disease models is sub segmented into oncology, cardiology, CNS, infectious diseases, dermatology, metabolic & genetic diseases and others

On the basis of end users, the CRISPR-CAS9 gene editing technologies market is segmented into biotechnology & pharmaceutical companies, academic & gove
ment research institutes, and others.

Regional Analysis

The global CRISPR-CAS9 gene editing technologies market is segmented into America, Europe, Asia Pacific and the Middle East & Africa. America dominates the global market owing to the well-developed technology, gove
ment support and increasing demand for the new and advanced products for the treatment of the various diseases.

Europe accounts for the second leading CRISPR-CAS9 gene editing technologies market due to strong gove
ment support and availability of the funds for research. Asia Pacific is the fastest growing market owing to presence of huge opportunity for the development of the market. Additionally, presence of rapidly growing economy has fueled the market growth in this region. 

On the other hand, the Middle East & Africa holds the least share in the CRISPR-CAS9 gene editing technologies market. Middle East holds the major share due to well developed technology and high spending on research.

Key Players

The key players in the CRISPR-CAS9 gene editing technologies market are: Thermo Fisher Scientific (U.S.), Merck & Co., Inc. (U.S.), Genscript (U.S.), Sangamo Therapeutics, Inc. (U.S.), Integrated DNA Technologies, Inc. (U.S.), Lonza (Switzerland), New England Biolabs (U.S.), CRISPR THERAPEUTICS (Switzerland), Mirus Bio LLC (U.S.), Takara Bio Inc. (Japan), Abbott Laboratories (U.S.), and Bio-Rad Laboratories, Inc. (U.S.).

Segmentation

Global CRISPR-CAS9 Gene Editing Technologies Market , By Application

Genome Engineering

Medicine

Agriculture

Research

Other

Disease models

Oncology

Cardiology

CNS

Infectious diseases

Dermatology

Metabolic and genetic diseases

Others

RNA editing

Knockdown/activation

Others

Global CRISPR-CAS9 Gene Editing Technologies Market , By End Users

Biotechnology & Pharmaceutical Companies

Academic & Gove
ment Research Institutes

Others

Major Companies In the market 

Others

Thermo Fisher Scientific

Merck & Co., Inc.

Genscript

Sangamo Therapeutics, Inc.

Integrated DNA Technologies, Inc.

Lonza 

New England Biolabs

CRISPR THERAPEUTICS

Mirus Bio LLC

Takara Bio Inc.

Abbott Laboratories 

Bio-Rad Laboratories, Inc.